Magnesium Sulphate in Oblique Subcostal TAP Block

• Status: Not yet recruiting
• Trial end date: 2025-02-20
• Target enrollment: 0
• Participant gender: All

Summary

The aim of this study is to evaluate the effect of adding different doses of MgSO4 to bupivacaine via OSCTAB block on postoperative pain control for 24 hours in patients scheduled for LC.

• Phase: Phase 2/Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Assiut University
• Treatments: Bupivacaine

Criteria

Inclusion Criteria:

• • Patients programmed for elective LC.

• American society of anesthesiologists (ASA) physical state I or II.

• Age over 18 years and less than 60 years old.

• Patients of both sex are included in the study.

Exclusion Criteria:

• • Patient refusal.

• Known hypersensitivity to the study drugs.

• Body Mass Index > 40 kg/m2.

• Inability to accurately describe postoperative pain to investigators.

• Opioid tolerance or dependence.

• Preexisting history of chronic pain.

• History of renal, liver, cardiac, neuropsychiatric disorder problems.

• Bleeding or coagulation abnormality.